78 related articles for article (PubMed ID: 12452777)
21. A transdermal drug delivery system based on dissolving microneedles for boron neutron capture therapy of melanoma.
Li J; Wang X; Wang Z; Zhao Y; Zhang Z; Li L; Ding D; Guo J; Zhang J; Liu H; Li Z
Biomater Sci; 2023 Nov; 11(23):7568-7578. PubMed ID: 37861462
[TBL] [Abstract][Full Text] [Related]
22. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease.
Busse PM; Harling OK; Palmer MR; Kiger WS; Kaplan J; Kaplan I; Chuang CF; Goorley JT; Riley KJ; Newton TH; Santa Cruz GA; Lu XQ; Zamenhof RG
J Neurooncol; 2003; 62(1-2):111-21. PubMed ID: 12749707
[TBL] [Abstract][Full Text] [Related]
23. Boronotyrosine, a Borylated Amino Acid Mimetic with Enhanced Solubility, Tumor Boron Delivery, and Retention for the Re-emerging Boron Neutron Capture Therapy Field.
Raitano A; Martin T; Zhang C; Malinao MC; Capo L; Ikeura M; Carroll R; Quintana JC; Dlamini S; Kulenovic L; Jahanshir E; Kang S; Morrison K; Torgov M; Morrison K
J Med Chem; 2023 Oct; 66(19):13809-13820. PubMed ID: 37729617
[TBL] [Abstract][Full Text] [Related]
24. Carborane-FAPI conjugate: A potential FAP-targeted boron agent with improved boron content.
Zhang J; Wu Y; Lu W; Xiao Y; Liu S; Yu J
Appl Radiat Isot; 2024 Jul; 209():111330. PubMed ID: 38657372
[TBL] [Abstract][Full Text] [Related]
25. Targeted strategies to deliver boron agents across the blood-brain barrier for neutron capture therapy of brain tumors.
Lan G; Song Q; Luan Y; Cheng Y
Int J Pharm; 2024 Jan; 650():123747. PubMed ID: 38151104
[TBL] [Abstract][Full Text] [Related]
26. Boronated Condensed DNA as a Heterochromatic Radiation Target Model.
Perry CC; Ramos-Méndez J; Milligan JR
Biomacromolecules; 2021 Apr; 22(4):1675-1684. PubMed ID: 33750108
[TBL] [Abstract][Full Text] [Related]
27. PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy.
Kim W; Won JY; Yi J; Choi SC; Lee SM; Mun K; Lim HS
Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543087
[TBL] [Abstract][Full Text] [Related]
28. Permeability of the blood-brain barrier to a rhenacarborane.
Hawkins PM; Jelliss PA; Nonaka N; Shi X; Banks WA
J Pharmacol Exp Ther; 2009 May; 329(2):608-14. PubMed ID: 19179541
[TBL] [Abstract][Full Text] [Related]
29. Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT).
Järvinen J; Pulkkinen H; Rautio J; Timonen JM
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140004
[TBL] [Abstract][Full Text] [Related]
30. Development of Brain-Tumor-Targeted Benzothiazole-Based Boron Complex for Boron Neutron Capture Therapy.
Yang JU; Kim S; Lee KC; Lee YJ; Kim JY; Park JA
ACS Med Chem Lett; 2022 Oct; 13(10):1615-1620. PubMed ID: 36262402
[TBL] [Abstract][Full Text] [Related]
31. Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier.
Tsujino K; Kashiwagi H; Nishimura K; Fujikawa Y; Kayama R; Fukuo Y; Hiramatsu R; Nonoguchi N; Takata T; Tanaka H; Suzuki M; Hu N; Ono K; Wanibuchi M; Nakai K; Nakamura H; Kawabata S
Neurooncol Adv; 2024; 6(1):vdae062. PubMed ID: 38770220
[TBL] [Abstract][Full Text] [Related]
32. Fluorinated BPA derivatives enhanced
Ding D; Mo S; Li Q; Wang F; Wang X; Ou C; Li Z
J Mater Chem B; 2024 Jun; ():. PubMed ID: 38836578
[TBL] [Abstract][Full Text] [Related]
33. Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells.
Schuller BW; Binns PJ; Riley KJ; Ma L; Hawthorne MF; Coderre JA
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3787-92. PubMed ID: 16505359
[TBL] [Abstract][Full Text] [Related]
34. Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.
Kellert M; Friedrichs JJ; Ullrich NA; Feinhals A; Tepper J; Lönnecke P; Hey-Hawkins E
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916755
[TBL] [Abstract][Full Text] [Related]
35. Development of a tumor control probability model for boron neutron capture therapy of head and neck cancer.
Hsu FY; Liu YH; Lin TY; Wang LW
Front Oncol; 2023; 13():1249074. PubMed ID: 38486932
[TBL] [Abstract][Full Text] [Related]
36. Radiation-induced bystander effect on the brain after fractionated spinal cord irradiation of aging rats.
Bálentová S; Hnilicová P; Kalenská D; Baranovičová E; Muríň P; Hajtmanová E
Neurochem Int; 2024 Jun; 176():105726. PubMed ID: 38556052
[TBL] [Abstract][Full Text] [Related]
37. REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA).
Henriksson R; Capala J; H-Stenstam B; Michanek A; Lindahl SK; Salford L; Franzén L; Blomquist E; Westlin JE; Bergenheim AT
Radiother Oncol; 2006 May; ():150-157. PubMed ID: 16698096
[TBL] [Abstract][Full Text] [Related]
38. Optimization of the classical oral cancerization protocol in hamster to study oral cancer therapy.
Santa Cruz IS; Garabalino MA; Trivillin VA; Itoiz ME; Pozzi ECC; Thorp S; Curotto P; Guidobono JS; Heber EM; Nigg DW; Schwint AE; Monti Hughes A
Oral Dis; 2020 Sep; 26(6):1175-1184. PubMed ID: 32297432
[TBL] [Abstract][Full Text] [Related]
39. Translational research of boron neutron capture therapy for spinal cord gliomas using rat model.
Kayama R; Tsujino K; Kawabata S; Fujikawa Y; Kashiwagi H; Fukuo Y; Hiramatsu R; Takata T; Tanaka H; Suzuki M; Hu N; Miyatake SI; Takami T; Wanibuchi M
Sci Rep; 2024 Apr; 14(1):8265. PubMed ID: 38594281
[TBL] [Abstract][Full Text] [Related]
40. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
